Global trends, trading activity of foreign investors and domestic macroeconomic data announcements would dictate terms in the equity market in a holiday-shortened week ahead, analysts said.
Equity markets would remain closed on Wednesday for Mahatma Gandhi Jayanti.
“Looking ahead, it will be interesting to monitor Foreign Institutional Investors (FIIs) and their flow into India. September saw the highest FII inflows into Indian equities this year. Movements in commodity prices, the US dollar index, and key macroeconomic data from the US will also be pivotal in shaping the market’s direction.
“Additionally, geopolitical developments will continue to be a key factor on the global stage,” said Santosh Meena, Head of Research, Swastika Investmart Ltd.
On the domestic front, upcoming monthly auto sales data and quarterly updates from companies could drive stock-specific movements in the near term, Meena said.
Among macroeconomic numbers, PMI (Purchasing Managers’ Index) data for the ..
Posts in category Business Standard
Markets to track global cues, trading activity in holiday-shortened week (29-09-2024)
RailTel Corporation bags order worth Rs 134.46-cr (28-09-2024)
RailTel Corporation of India informed that it has received a work order from Adani Connex for service aggregating to Rs 134.46 crore.
Lupin’s Pithampur facility completes USFDA inspection with 3 observations (28-09-2024)
Lupin announced that its Pithampur facility in Madhya Pradesh, which includes the unit-1 API and finished product manufacturing site, was inspected by the U.S. Food and Drug Administration (USFDA) from 16 September to 27 September 2024.
Zydus Life gets final approval from USFDA for cancer drug (28-09-2024)
Zydus Lifesciences announced that it has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Enzalutamide Capsules, 40 mg.
Zydus receives USFDA approval for Enzalutamide capsules (28-09-2024)
Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of patients with metastatic castration-resistant prostate cancer. Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad.
Zydus receives USFDA approval for Enzalutamide capsules (28-09-2024)
Enzalutamide capsules are androgen receptor inhibitors indicated for the treatment of patients with metastatic castration-resistant prostate cancer. Enzalutamide Capsules will be produced at the Group’s manufacturing site at Moraiya, Ahmedabad.
Bandhan Bank announces resignation of Chief Technology Officer (28-09-2024)
With effect from 24 December 2024
Bandhan Bank announces resignation of Chief Technology Officer (28-09-2024)
With effect from 24 December 2024
Alembic Pharma’s Gujarat unit gets EIR from USFDA (28-09-2024)
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) had issued an establishment inspection report (EIR) for its oral solid formulation facility (F-1) located in Panelav, Gujarat.
Alembic Pharma’s Gujarat unit gets EIR from USFDA (28-09-2024)
Alembic Pharmaceuticals announced that the United States Food and Drug Administration (USFDA) had issued an establishment inspection report (EIR) for its oral solid formulation facility (F-1) located in Panelav, Gujarat.